Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Cipla, B J Wadia Hospital enter partnership to set up paediatric palliative care unit

    Medical Dialogues Bureau7 Sept 2019 9:40 AM IST
    Cipla Foundation strongly believes that palliative care focuses on providing relief from symptoms and stress of illness at any point, yet most...
    Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales

    Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales

    Medical Dialogues Bureau7 Sept 2019 9:15 AM IST
    Roche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
    Sumitomo Dainippon Pharma to acquire 10pc stake in Roivant Sciences for USD 3 billion

    Sumitomo Dainippon Pharma to acquire 10pc stake in Roivant Sciences for USD 3 billion

    Medical Dialogues Bureau7 Sept 2019 9:00 AM IST
    The deal, which will open up new drug lines for Sumitomo Dainippon, will also give it the option to acquire interests in an additional six businesses,...
    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Medical Dialogues Bureau6 Sept 2019 1:03 PM IST
    The establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
    Bayer disagrees with German Government decision to ban Glyphosate from end of 2023

    Bayer disagrees with German Government decision to ban Glyphosate from end of 2023

    Medical Dialogues Bureau6 Sept 2019 9:00 AM IST
    "Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
    Payment of fees in Bharatkosh through Sugam portal: CDSCO issues notice

    Payment of fees in Bharatkosh through Sugam portal: CDSCO issues notice

    Farhat Nasim5 Sept 2019 5:26 PM IST
    In order to facilitate the payment of fees by the stakeholders, it has been decided by the Directorate that once the fees are debited from the account...
    Dr Reddys unveils generic version of Zyban ER tablets in US

    Dr Reddys unveils generic version of Zyban ER tablets in US

    Medical Dialogues Bureau5 Sept 2019 5:01 PM IST
    The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

    Medical Dialogues Bureau5 Sept 2019 9:15 AM IST
    ZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
    Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report

    Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report

    Medical Dialogues Bureau5 Sept 2019 9:00 AM IST
    Bilcare Research, which employs 1000 staff and has annual sales of 300 million euros, produces plastic packaging used in the pharmaceutical, consumer...
    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

    Medical Dialogues Bureau4 Sept 2019 5:18 PM IST
    New Delhi: Country's largest drugmaker, Sun Pharmaceuticals Ltd, (Sun Pharma) has been pulled up by the Advertising Standards Council of India (ASCI)...
    Former JnJ executive Marianne De Backer to lead Bayer pharma division

    Former JnJ executive Marianne De Backer to lead Bayer pharma division

    Medical Dialogues Bureau4 Sept 2019 9:30 AM IST
    Marianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
    Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab

    Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab

    Medical Dialogues Bureau3 Sept 2019 10:00 AM IST
    "The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok